No Data
No Data
Novavax Call Volume Above Normal and Directionally Bullish
Express News | State Reports Six Human Bird Flu Cases Now Confirmed in California - CDPH
Novavax (NVAX) Advances While Market Declines: Some Information for Investors
US stocks anomaly | Liley Financial raises the target price to $26 for Novavax (NVAX.US), up more than 3%.
On Thursday, novavax (NVAX.US) oscillated higher and rose more than 5% at one point, and as of the time of writing, it increased by over 3% to $13.08.
Novavax Analyst Ratings
B.Riley Financial Maintains Novavax(NVAX.US) With Buy Rating, Raises Target Price to $26
No Data
No Data